DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹3,881 Cr | ₹2,861 Cr | ₹1,823 Cr | ₹1,873 Cr | ₹1,263 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2023 | ₹3,881 Cr |
Mar2022 | ₹2,861 Cr |
Mar2021 | ₹1,823 Cr |
Mar2020 | ₹1,873 Cr |
Mar2019 | ₹1,263 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹3,881 Cr | 35.65 | |
Mar2022 | ₹2,861 Cr | 56.92 | |
Mar2021 | ₹1,823 Cr | -2.66 | |
Mar2020 | ₹1,873 Cr | 48.33 | |
Mar2019 | ₹1,263 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹103,857.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 6% | 2.8% | 93.1% | Stock Analytics | |
MANKIND PHARMA | ₹88,830.5 Cr | -4.2% | -4.7% | NA | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.7% |
9.4% |
21.4% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses